One regimen to consider for those commencing allopurinol at an early stage of gout presentation in a patient ... effects such as neuromyopathy [28] or drug interactions, as noted above.

allopurinol, with Ironwood’s lesinurad. Ironwood said the drug offers a dual mechanism of action treating inefficient excretion and overproduction of uric acid in gout patients. Gout is a ...

Stamp emphasized the importance of drug availability and noted that allopurinol is also the only medication for gout that is on the World Health Organization list of essential medications.

so the drug is often prescribed at lower doses and then gradually increased. In addition, allopurinol is typically given with colchicine to reduce the short-term risk of a gout attack. Allopurinol ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

you might be prescribed other treatments like Zyloprim (allopurinol) to help lower uric acid levels. For the best results for ...

CALGARY, Alberta, Jan. 17, 2025 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), ...

A new drug called febuxostat has been found to reduce plasma levels of uric acid more effectively in Gout than the currently used drug allopurinol. If the results of the clinical trial are ...

Allopurinol is prescribed to treat gouty arthritis and prevent specific kidney stones by reducing high uric acid levels in the blood. Aluminium can cause a decrease in the absorption of ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

The new drug development program - XRx-026 - will focus on the treatment of individuals who have gout and are intolerant to allopurinol. With the clinical development of XORLO TM 1 having advanced ...